Pregabalin as a treatment for painful diabetic peripheral neuropathy: a meta-analysis
- PMID: 18774507
- DOI: 10.1016/j.rapm.2008.02.012
Pregabalin as a treatment for painful diabetic peripheral neuropathy: a meta-analysis
Abstract
Background and objectives: Painful diabetic peripheral neuropathy (DPN) is an increasingly prevalent disorder that is best managed through a multimodal approach. We examined the effects of pregabalin on pain control, sleep disturbance, and the patient's global impression of change (PGIC) for the treatment of this disorder.
Methods: Studies were identified using the National Library of Medicine's PubMed and EMBase databases (1966 to July 15, 2007). Inclusion criteria were randomized trials comparing pregabalin to placebo in the treatment of DPN for adult patients. A total of 13 abstracts were identified of which 3 met inclusion criteria. Data were collected from each article and results were recorded. Primary outcome was pain at the conclusion of the study. Secondary outcomes included number of patients with 50% reduction in mean pain score, PGIC ratings at endpoint, and adverse events. A random-effects model was used.
Results: The 3 studies yielded 728 total subjects from 5 centers, of which 476 received pregabalin (dose range 75 to 600 mg/day) and 252 received placebo. Pregabalin treatment was associated with a significant decrease in pain scores (weighted mean difference, 1.15), higher likelihood to achieve at least a 50% reduction in mean pain score (relative risk [RR], 4.05), and improved PGIC ratings (RR = 1.45). Pregabalin was associated with an increased risk of somnolence, dizziness, and edema.
Conclusions: Pregabalin has significant effects on the pain associated with DPN as well as secondary endpoints that affect patients' quality of life.
Similar articles
-
Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.Clin Ther. 2011 Feb;33(2):159-66. doi: 10.1016/j.clinthera.2011.02.007. Epub 2011 Mar 27. Clin Ther. 2011. PMID: 21444113 Clinical Trial.
-
Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.Clin Ther. 2010 Dec;32(14):2370-85. doi: 10.1016/j.clinthera.2011.01.014. Clin Ther. 2010. PMID: 21353106 Clinical Trial.
-
Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta-analysis.Acta Anaesthesiol Scand. 2015 Feb;59(2):147-59. doi: 10.1111/aas.12420. Epub 2014 Oct 19. Acta Anaesthesiol Scand. 2015. PMID: 25328117
-
Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.Drug Saf. 2012 Oct 1;35(10):793-806. doi: 10.2165/11632660-000000000-00000. Drug Saf. 2012. PMID: 22967187 Review.
-
The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.Curr Med Res Opin. 2010 Oct;26(10):2411-9. doi: 10.1185/03007995.2010.516142. Curr Med Res Opin. 2010. PMID: 20812792 Review.
Cited by
-
Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy.Evid Based Complement Alternat Med. 2021 May 13;2021:9940169. doi: 10.1155/2021/9940169. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34093722 Free PMC article. Review.
-
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.Diabetes Metab J. 2023 Nov;47(6):743-756. doi: 10.4093/dmj.2023.0018. Epub 2023 Sep 6. Diabetes Metab J. 2023. PMID: 37670573 Free PMC article. Review.
-
Adding pregabalin or gabapentin for the management of community-treated patients with painful diabetic peripheral neuropathy: a comparative cost analysis.Clin Drug Investig. 2013 Nov;33(11):825-35. doi: 10.1007/s40261-013-0131-8. Clin Drug Investig. 2013. PMID: 24085589
-
Diabetic neuropathic pain: Physiopathology and treatment.World J Diabetes. 2015 Apr 15;6(3):432-44. doi: 10.4239/wjd.v6.i3.432. World J Diabetes. 2015. PMID: 25897354 Free PMC article. Review.
-
Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Ther Adv Drug Saf. 2014 Feb;5(1):38-56. doi: 10.1177/2042098613505614. Ther Adv Drug Saf. 2014. PMID: 25083261 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous